Designed for both oncologists and urologists, Dx/Rx: Genitourinary Oncology is a current, concise, quick reference guide to the diagnosis and therapy of cancers of the bladder/urothelial tract, kidneys, and testis. Tightly organized into a super-condensed outline-bulleted format, this handy, pocket-sized manual details precise, up-to-date information on the epidemiology, classification, diagnosis, treatment, and risk factors of genitourinary disorders. Throughout the book, tables and figures summarize important clinical data and current professional society recommendations, while salient references direct readers to additional information.

Designed for oncologists, urologists, and any other health professionals who care for urologic cancer patients, Dx/Rx: Genitourinary Oncology: Cancer of the Kidneys, Bladder, and Testis, Second Edition is a current, concise, quick reference guide to the diagnosis and therapy genito-urinary cancers. Tightly organized into a condensed outline-bulleted format, this pocket-sized reference offers precise and up-to-date information on the epidemiology, classification, diagnosis, treatment, and risk factors for cancers of the bladder/urothelial tract, kidneys, and testis. Throughout the book, tables and figures summarize important clinical data and current professional society recommendations, while salient references direct readers to additional information. The Second Edition includes three new chapters on metastatic urothelial carcinoma, localized renal carcinoma, and management of stages I and II nonseminoma. Presented in a handy, easy-to-read format, Dx/Rx: Genitourinary Oncology: Cancer of the Kidneys, Bladder, and Testis, Second Edition is a must-have guide for use on the ward or in the clinic. Also available in mobile app!

Designed For Both Oncologists And Urologists, Dx/Rx: Genitourinary Oncology Is A Current, Concise, Quick Reference Guide To The Diagnosis And Therapy Of Cancers Of The Bladder/Urothelial Tract, Kidneys, And Testis. Tightly Organized Into A Super-Condensed Outline-Bulleted Format, This Handy, Pocket-Sized Manual Details Precise, Up-To-Date Information On The Epidemiology, Classification, Diagnosis, Treatment, And Risk Factors Of Genitourinary Disorders. Throughout The Book, Tables And Figures Summarize Important Clinical Data And Current Professional Society Recommendations, While Salient References Direct Readers To Additional Information.

Current information on the etiology, diagnosis, and treatment of carcinomas of the kidney and testis, as well as several less common tumors of the genitourinary tract. Recent contributions in epidemiology and molecular genetics are discussed with a view to their importance for clinical practice, while novel approaches to the treatment of several important tumors are presented, with emphasis on multidisciplinary patient management. Numerous illustrations assist readers in obtaining a better understanding of the data presented.

Dx/Rx: Liver Cancer is a quick and practical reference guide containing all aspects of the diagnosis and therapy of hepatocellular carcinoma (HCC), prognostic and staging systems, clinical management, molecular biology, current controversies, and future insights. Organized into a condensed, bulleted format, this concise reference offers precise and up-to-date information on the epidemiology, classification, diagnosis, treatment, and risk factors for cancers of the liver. Presented in a handy, easy-to-read format, Dx/Rx: Liver Cancer is a must-have resource for oncologists, internists, primary care physicians, and other health care professionals on the ward or in the clinic.

Completely revised and updated for 2015, the Physicians' Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens--both on- and off-label--for the treatment of all the major cancers. SPECIAL FEATURES: -Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like afatinib, ceritinib, ibrutinib, idelalisib, obinutuzumab, and ramucirumab. -A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens. -Diagrams of drug structures and pathways for many of the agents. -Offers a comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages. -Covers toxicity and drug-drug interactions. -A section on chemotherapy regimens for all major cancers. -Provides an overview of the basic principles of cancer drug therapy.

Written by world-class experts in clinical cancer therapeutics, Physicians’ Cancer Chemotherapy Drug Manual 2017 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers.

Written by world-class experts in clinical cancer therapeutics, Physicians’ Cancer Chemotherapy Drug Manual 2018 provides a complete, easy-to-use catalog of over 100 drugs and commonly used drug regimens—both on- and off-label—for the treatment of all the major cancers.